Skip to main content

and
  1. Article

    Open Access

    Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania

    This study assessed the safety of the new World Health Organization (WHO) recommendation of adding a single low-dose of primaquine (PQ) to standard artemisinin-based combination therapy (ACT), regardless of in...

    Richard Mwaiswelo, Billy E. Ngasala, Irina Jovel, Roland Gosling in Malaria Journal (2016)

  2. Article

    Open Access

    Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial

    The World Health Organization (WHO) recently recommended the addition of a single low-dose of the gametocytocidal drug primaquine (PQ) to artemisinin-based combination therapy (ACT) in low transmission setting...

    Richard Mwaiswelo, Billy Ngasala, Dr Irina Jovel, Berit Aydin-Schmidt in Malaria Journal (2016)

  3. Article

    Open Access

    Evaluation of residual submicroscopic Plasmodium falciparum parasites 3 days after initiation of treatment with artemisinin-based combination therapy

    Plasmodium falciparum resistance against artemisinin has not emerged in Africa; however, there are reports of the presence of polymerase chain reaction-determined residual submicroscopic parasitaemia detected on ...

    Richard Mwaiswelo, Bill Ngasala in Malaria Journal (2020)

  4. Article

    Open Access

    Efficacy of artesunate-amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in mainland Tanzania

    Diversification of artemisinin-based combination therapy (ACT) is suggested as one of the strategies that can be used to contain artemisinin resistance. Artesunate-amodiaquine (ASAQ) is one of the artemisinin-...

    Billy Ngasala, Samwel Bushukatale, Mercy Chiduo, Twilumba Makene in Malaria Journal (2024)